American Society of Hirudotherapy

Poly-paraphyly of Hirudinidae: many lineages of medicinal leeches

Phylogenetics article published in BMC Evolutionary Biology (2009)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Genomics & ProteomicsPhillips AJ, Siddall ME · BMC evolutionary biology, 2009

Abstract

BACKGROUND: Medicinal leeches became infamous for their utility in bloodletting popularized in the 19th century, and have seen a recent resurgence in post-operative treatments for flap and replantation surgeries, and in terms of characterization of salivary anticoagulants. Notorious throughout the world, the quintessential leech family Hirudinidae has been taken for granted to be monophyletic, as has the non-bloodfeeding family Haemopidae. RESULTS: This study is the first to evaluate molecular evidence from hirudinid and haemopid leeches in a manner that encompasses the global scope of their taxonomic distributions. We evaluated the presumed monophyly of the Hirudinidae and assessed previous well-accepted classification schemes. The Hirudinidae were found not to be monophyletic, falling instead into two distinct and unrelated clades. Members of the non-bloodfeeding family Haemopidae were scattered throughout the tree and among traditional hirudinid genera. A combination of nuclear 18S rDNA and 28S rDNA with mitochondrial 12S rDNA and cytochrome c oxidase I were analyzed with Parsimony and with Bayesian methods. CONCLUSION: The family Hirudinidae must be refined to include only the clade containing Hirudo medicinalis (European medicinal leech) and related leeches irrespective of bloodfeeding behavior. A second clade containing Macrobdella decora (North American medicinal leech) and its relatives may yet be recognized in Semiscolecidae in order to avoid paraphyly. The African distribution of species from each of the divergent hirudinid clades suggests that a deep divergence took place in the history of the medicinal leeches hundreds of millions of years ago.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
Indexed MeSH termsAnimalsDNA, MitochondrialEvolution, MolecularLeechesPhylogenyRNA, Ribosomal, 18SRNA, Ribosomal, 28SSequence Analysis, DNA

Summary

Combined nuclear (18S, 28S) and mitochondrial (12S, COI) phylogenetic analysis demonstrates Hirudinidae are not monophyletic but fall into two distinct clades, with implications for understanding the evolution of medicinal leech bloodfeeding.

Why This Matters for Hirudotherapy

This phylogenetic study used nuclear 18S and 28S rDNA plus mitochondrial 12S rDNA and cytochrome c oxidase I sequences, analyzed by parsimony and Bayesian methods, to test the presumed monophyly of the leech family Hirudinidae (medicinal leeches) and Haemopidae across their global distributions. The Hirudinidae were found not to be monophyletic, splitting into two distinct clades—one containing Hirudo medicinalis and relatives, another containing Macrobdella decora and relatives (potentially recognizable as Semiscolecidae)—with Haemopidae scattered among traditional hirudinid genera and an ancient African divergence suggested. For ASH, this is relevant background on the taxonomy and evolutionary relationships of medicinal leeches. Caveat: this is a molecular phylogenetics/taxonomy study with no therapeutic, secretome, or hirudotherapy data.

Citation

Poly-paraphyly of Hirudinidae: many lineages of medicinal leeches.

Phillips AJ, Siddall ME · BMC evolutionary biology, 2009

Added to ASH library: May 26, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.